Endexx Contributes to Diabetic Neuropathy Case Study

CAVE CREEK, AZ--(Marketwired - Dec 9, 2014) - Endexx Corporation (OTC PINK: EDXC) announced today that it is providing its CBD (Cannabidiol) starter kit (M3Vape) to a voluntary patient study utilizing industrial hemp oil that is rich in CBD/CBDa, as an application to potentially alleviate symptoms arising from diabetic neuropathy. Thirteen diabetic patients suffering from neuropathy in Missouri began a 30 day voluntary study in late November under the oversight of Dr. Daniel Kiddy, DPM. Dr. Kiddy stated, "The main objective for this short study is to simply see if pain is decreased or eliminated. We are also monitoring if the proprioception and sharp and dull sensation are improved."

Endexx's "Cannsumable" Division is developing two primary product lines derived from food grade and lab-tested industrial hemp oil. The oil is naturally rich in both CBD and CBDa phytocannabinoids. The industrial hemp is grown on a certified eco-farm under organic farming practices. The oil is extracted utilizing critical CO2 extraction processes. The oil is tested both at the manufacturing site and in the United States at a certified lab. The product has no heavy metals, pesticides, or other contaminants and is tested using microbiological methods for determining mold and bacteria levels.

Endexx is researching the highest quality sources of industrial hemp oil that achieves the following primary goals:
(i) The product must be safe.
(ii) The product must be legal under federal law.
(iii) The product must provide maximum bioavailability.
(iv) The product must be beneficial to the patient/consumer.

Consumer and patient safety is Endexx's foremost concern.

This study is not an official clinical trial. The study will provide general feedback from patients anecdotally, providing information to the doctors, patients and providers of the product. Public awareness of cannabis and industrial hemp products containing therapeutic and wellness properties has escalated over the past few years, yet education and research is limited. Understanding the benefits and the negatives of any supplement or nutraceutical is critical when determining the direction of a product's development and future use by the medical community and/or the general adult population.